Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
2.
Comput Biol Med ; 73: 173-85, 2016 06 01.
Article in English | MEDLINE | ID: mdl-27208610

ABSTRACT

BACKGROUND: The continuous growth of medical sciences literature indicates the need for automated text analysis. Scientific writing which is neither unitary, transcending social situation nor defined by a timeless idea is subject to constant change as it develops in response to evolving knowledge, aims at different goals, and embodies different assumptions about nature and communication. The objective of this study was to evaluate whether publication dates should be considered when performing text mining. METHODS: A search of PUBMED for combined references to chemokine identifiers and particular cancer related terms was conducted to detect changes over the past 36 years. Text analyses were performed using freeware available from the World Wide Web. TOEFL Scores of territories hosting institutional affiliations as well as various readability indices were investigated. Further assessment was conducted using Principal Component Analysis. Laboratory examination was performed to evaluate the quality of attempts to extract content from the examined linguistic features. RESULTS: The PUBMED search yielded a total of 14,420 abstracts (3,190,219 words). The range of findings in laboratory experimentation were coherent with the variability of the results described in the analyzed body of literature. Increased concurrence of chemokine identifiers together with cancer related terms was found at the abstract and sentence level, whereas complexity of sentences remained fairly stable. CONCLUSIONS: The findings of the present study indicate that concurrent references to chemokines and cancer increased over time whereas text complexity remained stable.


Subject(s)
Data Mining/methods , Internet , Neoplasms , PubMed , Animals , Humans
3.
Cancer Res ; 75(24): 5248-59, 2015 Dec 15.
Article in English | MEDLINE | ID: mdl-26631268

ABSTRACT

Cervical cancer is a consequence of persistent infection with human papillomaviruses (HPV). Progression to malignancy is linked to an inflammatory microenvironment comprising T-helper-17 (Th17) cells, a T-cell subset with protumorigenic properties. Neoplastic cells express only low endogenous levels of the Th17 chemoattractant CCL20, and therefore, it is unclear how Th17 cells are recruited to the cervical cancer tissue. In this study, we demonstrate that CCL20 was predominantly expressed in the stroma of cervical squamous cell carcinomas in situ. This correlated with stromal infiltration of CD4(+)/IL17(+) cells and with advancing International Federation of Gynecology and Obstetrics (FIGO) stage. Furthermore, we show that cervical cancer cells instructed primary cervical fibroblasts to produce high levels of CCL20 and to attract CD4/IL17/CCR6-positive cells, generated in vitro, in a CCL20/CCR6-dependent manner. Further mechanistic investigations identified cervical cancer cell-derived IL6 as an important mediator of paracrine CCL20 induction at the promoter, mRNA, and protein level in fibroblasts. CCL20 was upregulated through the recently described CCAAT/enhancer-binding protein ß (C/EBPß) pathway as shown with a dominant-negative version of C/EBPß and through siRNA-mediated knockdown. In summary, our study defines a novel molecular mechanism by which cervical neoplastic cells shape their local microenvironment by instructing fibroblasts to support Th17 cell infiltration in a paracrine IL6/C/EBPß-dependent manner. Th17 cells may in turn maintain chronic inflammation within high-grade cervical lesions to further promote cancer progression.


Subject(s)
Lymphocytes, Tumor-Infiltrating/immunology , Th17 Cells/immunology , Tumor Microenvironment/immunology , Uterine Cervical Dysplasia/pathology , Uterine Cervical Neoplasms/pathology , Blotting, Western , Carrier Proteins/immunology , Cells, Cultured , Chemokine CCL20/immunology , Chemotaxis, Leukocyte/immunology , Disease Progression , Enzyme-Linked Immunosorbent Assay , Female , Fibroblasts/immunology , Flow Cytometry , Fluorescent Antibody Technique , HeLa Cells , Humans , Immunohistochemistry , Interleukin-6/immunology , RNA, Small Interfering , RNA-Binding Proteins , Real-Time Polymerase Chain Reaction , Signal Transduction/immunology , Transfection , Uterine Cervical Neoplasms/immunology , Uterine Cervical Dysplasia/immunology
4.
Oncotarget ; 6(11): 8635-47, 2015 Apr 20.
Article in English | MEDLINE | ID: mdl-25888634

ABSTRACT

Previous studies have shown that cervical cancer cells only release low levels of pro-inflammatory cytokines owing to infection with human papillomaviruses. This results in low immunogenicity of the cancer cells. The viral dsRNA analog PolyIC has been suggested as a promising adjuvant for cervical cancer immunotherapy. However, little is known about the molecular requirements resulting in successful immune activation. Here, we demonstrate that stimulation of cervical cancer cells with PolyIC induced necroptotic cell death, which was strictly dependent on the expression of the receptor-interacting protein kinase RIPK3. Necroptotic cancer cells released interleukin-1α (IL-1α), which was required for powerful activation of dendritic cells (DC) to produce IL-12, a cytokine critical for anti-tumor responses. Again both, IL-1α release and DC activation, were strictly dependent on RIPK3 expression in the tumor cells. Of note, our in situ analyses revealed heterogeneous RIPK3 expression patterns in cervical squamous cell carcinomas and adenocarcinomas. In summary, our study identified a novel RIPK3-dependent mechanism that explains how PolyIC-treatment of cervical cancer cells leads to potent DC activation. Our findings suggest that the RIPK3 expression status in cervical cancer cells might critically influence the outcome of PolyIC-based immunotherapeutic approaches and should therefore be assessed prior to immunotherapy.


Subject(s)
Adenocarcinoma/pathology , Carcinoma, Squamous Cell/pathology , Interferon Inducers/pharmacology , Interleukin-1alpha/metabolism , Neoplasm Proteins/physiology , Paracrine Communication/drug effects , Poly I-C/pharmacology , Receptor-Interacting Protein Serine-Threonine Kinases/physiology , Uterine Cervical Neoplasms/pathology , Adenocarcinoma/immunology , Adenocarcinoma/metabolism , Adenocarcinoma/virology , Apoptosis/drug effects , Carcinoma, Squamous Cell/immunology , Carcinoma, Squamous Cell/metabolism , Carcinoma, Squamous Cell/virology , Caspase 3/physiology , Dendritic Cells/immunology , Female , Gene Expression Regulation, Neoplastic , HMGB1 Protein/metabolism , HeLa Cells , Humans , Interleukin-12/biosynthesis , Interleukin-12/genetics , Necrosis , Neoplasm Proteins/biosynthesis , Neoplasm Proteins/genetics , Neoplasm Proteins/metabolism , Papillomaviridae/drug effects , Papillomavirus Infections/immunology , Papillomavirus Infections/pathology , Papillomavirus Infections/virology , RNA Interference , RNA, Small Interfering/genetics , Receptor-Interacting Protein Serine-Threonine Kinases/biosynthesis , Receptor-Interacting Protein Serine-Threonine Kinases/genetics , Uterine Cervical Neoplasms/immunology
5.
Mol Genet Genomics ; 289(6): 1085-101, 2014 Dec.
Article in English | MEDLINE | ID: mdl-24938624

ABSTRACT

The present study is one of the few that includes tissue samples in the evaluation of target prediction algorithms designed to detect microRNA (miRNA) sequences that might interact with particular messenger RNA (mRNA) sequences. Twelve different target prediction tools were used to find miRNA sequences that might interact with CCL20 gene expression. Different algorithms predicted controversial miRNA sequences for CCL20 regulation due to a different weighting of parameters. Hsa-miR-21 and hsa-miR-145 suggested by four or more programs were chosen for further investigation. Possible real interaction of these miRNA sequences with CCL20 gene expression was monitored using luciferase assays and expression analyses of tissue samples of colorectal adenocarcinoma by either qRT-PCR or ELISA. Folding status of seed-binding sites in complete mRNA and 3'UTR of CCL20 was predicted. Prediction of miRNA expression was attempted based on CCL20 expression data. Eight of the target prediction tools forecasted a role for hsa-miR-21 and four mentioned hsa-miR-145 in CCL20 gene regulation. Laboratory experimentation showed that CCL20 may serve as a target of hsa-miR-21 but not hsa-miR-145. Expression of the molecules resulted in no clear assertion. Folding of seed-binding sites was predicted to be relatively constant for the complete mRNA and 3'UTR. Predicting miRNA expression based on target gene expression was impossible. This might be attributable to the fact that effects of miRNA activity may oscillate between gene product repression and activation. Additional systematic studies are needed to address this issue.


Subject(s)
Algorithms , Chemokine CCL20/genetics , MicroRNAs/metabolism , RNA, Messenger/chemistry , 3' Untranslated Regions , Adult , Aged , Aged, 80 and over , Binding Sites , Colorectal Neoplasms/genetics , Colorectal Neoplasms/mortality , Female , Humans , Male , MicroRNAs/chemistry , Middle Aged , RNA Folding , RNA, Messenger/metabolism , Regulatory Sequences, Ribonucleic Acid , Software
6.
Oncol Rep ; 30(3): 1285-92, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23817679

ABSTRACT

Recently, we reported a functional interaction between miR-21 and its identified chemokine target CCL20 in colorectal cancer (CRC) cell lines. Here, we investigated whether such functional interactions are permitted at the cellular level which would require an inverse correlation of expression and also co-expression of miR-21 and CCL20 in the same cell. Expression profiling was performed using qPCR, and ELISA, in situ hybridization and immunohistochemistry were applied for the presentation of their cellular localization. We demonstrated that miR-21 as well as CCL20 were both significantly upregulated in CRC tissues; thus, showing no antidromic expression pattern. This provided an initial clue that miR-21 and CCL20 may not be expressed in the same cell. In addition, we located miR-21 expression at the cellular level predominantly in stromal cells such as tumor-associated fibroblasts and to a minor degree in immune cells such as macrophages and lymphocytes. Likewise, CCL20 expression was primarily detected in tumor-infiltrating immune cells. Thus, investigating the cellular localization of miR-21 and its target CCL20 revealed that both molecules are expressed predominantly in the microenvironment of CRC tumors.


Subject(s)
Chemokine CCL20/metabolism , Colorectal Neoplasms/genetics , Fibroblasts/metabolism , Gene Expression Regulation, Neoplastic , MicroRNAs/genetics , Stromal Cells/metabolism , Tumor Microenvironment , Adult , Aged , Aged, 80 and over , Cell Proliferation , Chemokine CCL20/genetics , Cohort Studies , Colorectal Neoplasms/metabolism , Colorectal Neoplasms/pathology , Enzyme-Linked Immunosorbent Assay , Female , Fibroblasts/pathology , Follow-Up Studies , Humans , Immunoenzyme Techniques , In Situ Hybridization , Male , Middle Aged , Neoplasm Grading , Neoplasm Staging , Prognosis , RNA, Messenger/genetics , Real-Time Polymerase Chain Reaction , Reverse Transcriptase Polymerase Chain Reaction , Stromal Cells/pathology
7.
Cancer Lett ; 316(1): 105-12, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22099878

ABSTRACT

As deregulation of miRNAs and chemokine CCL20 was shown to play a role in colorectal cancer (CRC) pathogenesis, we analyzed the functional interactions of candidate miRNAs with CCL20 mRNA. After target prediction software programs indicated a role for miR-21 in CCL20 regulation, we applied the luciferase reporter assay system to demonstrate that miR-21 functionally interacts with the 3'UTR of CCL20 mRNA and down-regulates CCL20 in miR-21 mimic transfected CRC cell lines (Caco-2, SW480 and SW620). Thus, regulation of CCL20 expression by miR-21 might be a regulatory mechanism involved in progression of CRC.


Subject(s)
3' Untranslated Regions , Chemokine CCL20/biosynthesis , Colorectal Neoplasms/genetics , MicroRNAs/genetics , MicroRNAs/metabolism , Caco-2 Cells , Cell Line, Tumor , Chemokine CCL20/genetics , Chemokine CCL20/metabolism , Colorectal Neoplasms/metabolism , Down-Regulation , Humans , Mutagenesis, Site-Directed/methods , RNA, Messenger/genetics , Transfection/methods
8.
J Transl Med ; 9: 22, 2011 Feb 24.
Article in English | MEDLINE | ID: mdl-21349176

ABSTRACT

BACKGROUND: Interactions between CXCR4 and its ligand CXCL12 have been shown to be involved in cancer progression in colorectal cancer (CRC). We performed a comparative CXCL12/CXCR4 expression analysis and assessed the effect of external CXCL12 stimulation on migration of CRC cells without and with CXCR4 inhibition. METHODS: Expression of CXCL12/CXCR4 was assessed by quantitative real-time PCR, ELISA and immunohistochemistry in resection specimens of 50 CRC patients as well as in the corresponding normal tissues and in three human CRC cell lines with different metastatic potential (Caco-2, SW480 and HT-29). Migration assays were performed after stimulation with CXCL12 and CXCR4 was inhibited by siRNA and neutralizing antibodies. RESULTS: In CRC tissues CXCL12 was significantly down-regulated and CXCR4 was significantly up-regulated compared to the corresponding normal tissues. In cell lines CXCR4 was predominantly expressed in SW480 and less pronounced in HT-29 cells. CXCL12 was only detectable in Caco-2 cells. CXCL12 stimulation had no impact on Caco-2 cells but significantly increased migration of CXCR4 bearing SW480 and HT-29 cells. This effect was significantly abrogated by neutralizing anti-CXCR4 antibody as well as by CXCR4 siRNAs (P < 0.05). CONCLUSIONS: CXCR4 expression was up-regulated in CRC and CXCL12 stimulation increased migration in CXCR4 bearing cell lines. Migration was inhibited by both neutralizing CXCR4 antibodies and CXCR4 siRNAs. Thus, the expression and functionality of CXCR4 might be associated with the metastatic potential of CRC cells and CXCL12/CXCR4 interactions might therefore constitute a promising target for specific treatment interventions.


Subject(s)
Cell Movement , Chemokine CXCL12/metabolism , Colorectal Neoplasms/genetics , Colorectal Neoplasms/pathology , Gene Silencing , Receptors, CXCR4/genetics , Aged , Antibodies, Blocking/pharmacology , Cell Line, Tumor , Cell Movement/drug effects , Cell Proliferation/drug effects , Chemokine CXCL12/genetics , Colorectal Neoplasms/immunology , Enzyme-Linked Immunosorbent Assay , Female , Gene Expression Regulation, Neoplastic/drug effects , Gene Knockdown Techniques , Gene Silencing/drug effects , Humans , Male , Middle Aged , Organ Specificity/drug effects , Organ Specificity/genetics , RNA, Messenger/genetics , RNA, Messenger/metabolism , Receptors, CXCR4/metabolism
9.
J Transl Med ; 8: 45, 2010 May 10.
Article in English | MEDLINE | ID: mdl-20459729

ABSTRACT

BACKGROUND: CCL20 and its receptor CCR6 have been shown to play a role in the onset, development and metastatic spread of various gastrointestinal malignancies. In this study, the expression profile and clinical significance of the CCL20/CCR6 system in distinct benign, pre-malignant and malignant pancreatic tissues was investigated. METHODS: Using RealTime-PCR, enzyme-linked immunosorbent assay (ELISA), Western Blot and immunohistochemistry, we have analyzed the expression profile of CCL20/CCR6 in resection specimens from patients with chronic pancreatitis (CP) (n = 22), pancreatic cystadenoma (PA) (n = 11) and pancreatic carcinoma (PCA) (n = 25) as well as in the respective matched normal pancreatic tissues. RESULTS: CCL20 mRNA and protein was weakly expressed in normal pancreatic tissues and CP and PA specimens but significantly up-regulated in PCA (8-fold) as compared to the matched normal tissue (P < 0.05). Moreover, CCL20 mRNA and protein expression was significantly associated with advanced T-category in patients with PCA (P < 0.05). CCR6 mRNA showed a significant up-regulation in all three disease entities as compared to normal tissues (P < 0.05, respectively). CONCLUSION: CCL20 and CCR6 were significantly up-regulated in PCA as compared to the normal pancreatic tissue and CCL20 was significantly associated with advanced T-category in PCA patients. This suggests that CCL20 and CCR6 play a role in the development and progression of PCA and may constitute potential targets for novel treatment strategies.


Subject(s)
Chemokine CCL20/genetics , Gene Expression Profiling , Gene Expression Regulation, Neoplastic , Pancreatic Neoplasms/genetics , Receptors, CCR6/genetics , Adult , Aged , Chemokine CCL20/metabolism , Enzyme-Linked Immunosorbent Assay , Female , Humans , Male , Middle Aged , Neoplasm Staging , Pancreatic Neoplasms/pathology , RNA, Messenger/genetics , RNA, Messenger/metabolism , Receptors, CCR6/metabolism , Reverse Transcriptase Polymerase Chain Reaction
SELECTION OF CITATIONS
SEARCH DETAIL
...